Evidence map›Paper›PMID 31413642›Full record

ArticleHIV/AIDS (Auckland, N.Z.)2019

Comorbidities in a sample of adults with HIV in Puerto Rico: an exploratory study.

Carlos E Rodríguez-Díaz, Edda I Santiago-Rodríguez, Gerardo G Jovet-Toledo, Jorge Santana-Bagur, Yemile Ron-Suarez, Juan C Orengo, Felipe Arbelaez, Homero Monsanto

Open access · goldAbstract read
In one paragraph

Article in HIV/AIDS (Auckland, N.Z.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Carlos E Rodríguez-DíazThe George Washington University, Milken Institute School of Public Health, Washington, DC, USA.
Edda I Santiago-RodríguezUniversity of California, San Francisco, Center for Aids Prevention Studies, San Francisco, CA, USA.
Gerardo G Jovet-ToledoUniversity of Puerto Rico-medical Sciences Campus, School of Public Health, San Juan, PR, USA.
Jorge Santana-BagurUniversity of Puerto Rico-medical Sciences Campus, School of Medicine, San Juan, PR, USA.
Yemile Ron-SuarezMerck & Co., Inc., Medical Affairs, Carolina, PR, USA.
Juan C OrengoPonce Health Sciences University, Public Health Program, Ponce, PR, USA.
Felipe ArbelaezMerck & Co., Inc., Medical Affairs, Carolina, PR, USA.
Homero MonsantoMerck & Co., Inc., Medical Affairs, Carolina, PR, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Puerto Rico, Medical Sciences Campus · PRMilken Institute · USPonce Health Sciences University · PRUniversity of California, San Francisco · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
University of Puerto Rico Mentoring Institute for HIV Mental Health ResearchR25MH083617 · NIMH · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ZORRILLA, CARMEN D · 2008 to 2020
$3.7M
NIMH NIH HHS P30 MH062246NIMH NIH HHS R25 MH083617NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

backgroundPuerto Rico is among the areas with the highest estimated rates of people living with HIV in the United States. Despite the epidemiologic data available, there is limited real-world information that can help understand the comorbidities of people with HIV. In this study, we describe common comorbidities among adults with HIV attending treatment clinics in Puerto Rico.

methodsAn exploratory, retrospective, cross-sectional study was conducted at five HIV clinics in Puerto Rico. A random sample of medical records was reviewed. Descriptive statistics were used to summarize patient demographics, morbidity, and clinical characteristics. Multivariate analyses were conducted to explore comorbidities by age and sex.

resultsA total of 250 (179 men; 71 women) medical records were reviewed. Participants' mean age was 47.9 years and on average they had been living with HIV for 9 years. Most (97.6%) had at least one comorbidity. The most common comorbidities were dyslipidemia and hypertension. Men were more likely to have been diagnosed with alcohol misuse while women were more likely to have been diagnosed with obesity, human papillomavirus (HPV), hypothyroidism, and osteoporosis. Participants younger than 50 years of age were more likely to have history of alcohol misuse while older individuals (50 years and old) were more likely to have been diagnosed with dyslipidemia, hypertension, and diabetes. Adjusting by sex and age, women were more likely to have been diagnosed with obesity and depression and those older than 50 years were more likely to have had a diagnosis of dyslipidemia, hypertension, HPV, and diabetes.

conclusionsThis is one of the few studies assessing comorbidities among adults with HIV in Puerto Rico, among Latino/Hispanics within the United States, and Latin America. Consistent with other studies, cardiovascular diseases are common among adults with HIV in Puerto Rico. Findings support the need for awareness and real-world evidence about comorbidities among people with HIV when implementing screenings and prescribing drugs.

Indexed as

comorbiditiesHIVPuerto Rico

Identifiers

PMID31413642
PMCPMC6661978
OpenAlexW2962887626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.